A-423579

From Food & Medicine Encyclopedia

File:A-423,579.svg
A-423,579.svg
A-423579
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


A-423579 is a chemical compound that has been studied for its potential pharmacological properties. It is known to interact with specific receptors in the central nervous system and has been the subject of research in the field of neuropharmacology.

Chemical Properties[edit]

A-423579 has a complex molecular structure, which includes several functional groups that contribute to its activity. The exact IUPAC name and molecular formula are essential for understanding its chemical behavior and interactions.

Pharmacology[edit]

A-423579 has been shown to have an affinity for certain neurotransmitter receptors, which may make it useful in the treatment of various neurological disorders. Research has indicated that it may influence the dopaminergic system, which is involved in the regulation of mood, reward, and motor control.

Research and Development[edit]

Studies on A-423579 are ongoing, with a focus on its potential therapeutic applications. It has been investigated in preclinical models for its effects on anxiety, depression, and other mental health conditions. The compound's safety profile and pharmacokinetics are also areas of active research.

Potential Applications[edit]

The potential applications of A-423579 in medicine are diverse. It may be developed as a treatment for psychiatric disorders, neurodegenerative diseases, and other conditions that involve dysregulation of the central nervous system.

See Also[edit]

References[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.